Background and Aims The coronavirus‐19 disease (COVID‐19) pandemic, caused by the
severe acute respiratory syndrome coronavirus 2 virus, is associated with significant …

Introduction & objectives The independent effect of liver biochemistries as a prognostic
factor in patients with COVID-19 has not been completely addressed. We aimed to evaluate …

Background & Aims Recent data on the coronavirus disease 2019 (COVID-19) outbreak
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has begun …

Recent data on the coronavirus disease 2019 (COVID-19) outbreak caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has begun to shine light on the …

Objective Liver injury has frequently been reported in COVID-19 patients. The clinical
relevance of liver injury related to SARS-CoV-2 infection remains unclear with a need for …

Background and Aims Coronavirus disease 2019 (COVID‐19) has been associated with
acute liver injury (ALI) manifested by increased liver enzymes in reports worldwide …

Background and aims Coronavirus disease 2019 (COVID-19) pandemic is ongoing. Except
for lung injury, it is possible that COVID-19 patients develop liver injury. Thus, we conducted …

Objective Data on serial liver biochemistries of patients infected by different human
coronaviruses (HCoVs) are lacking. The impact of liver injury on adverse clinical outcomes …

Background & Aims The evolution and clinical significance of abnormal liver chemistries and
the impact of hepatitis B infection on outcome in patients with COVID-19 is not well …

Introduction and objectives The incidence of liver injury (LI) in hospitalized COVID-19
patients ranged from 14% to 53% based on sole or multiple elevated indexes for LI. The …